ROBERTA WATTS: Open Payments
NPI 1104254572 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,338 in 219 payments from 31 companies in 2025. Trend: 2023 $3,651 · 2024 $3,140 · 2025 $3,338
Food & beverage: $3,338
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $506 |
| Otsuka America Pharmaceutical, Inc. | 31 | $503 |
| AstraZeneca Pharmaceuticals LP | 17 | $411 |
| PFIZER INC. | 15 | $270 |
| Vanda Pharmaceuticals Inc. | 24 | $254 |
| Amgen Inc. | 25 | $244 |
| Lundbeck LLC | 12 | $166 |
| GlaxoSmithKline, LLC. | 11 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Lilly USA, LLC | 4 | $75 |
Products named: REXULTI, BREZTRI, NURTEC ODT, VRAYLAR, OTEZLA, ABILIFY MAINTENA, UBRELVY, FANAPT.
Industry payments across OH — which companies pay providers there.
